Pfenex Inc. (PFNX) Soars 5.8% on August 29

Pfenex Inc. (PFNX) Soars 5.8% on August 29

Pfenex Inc. (PFNX) had a good day on the market for Wednesday August 29 as shares jumped 5.8% to close at $5.29. About 239,610 shares traded hands on 1,534 trades for the day, compared with an average daily volume of 203,512 shares out of a total float of 31.43 million. After opening the trading day at $4.97, shares of Pfenex Inc. stayed within a range of $5.39 to $4.97.

With today’s gains, Pfenex Inc. now has a market cap of $166.24 million. Shares of Pfenex Inc. have been trading within a range of $8.42 and $2.07 over the last year, and it had a 50-day SMA of $5.22 and a 200-day SMA of $4.54.

Pfenex Inc is a clinical-stage biotechnology company. It is engaged in the development of biosimilar and therapeutic equivalent products to branded therapeutics and difficult-to-manufacture proteins.

Pfenex Inc. is based out of San Diego, CA and has some 68 employees. Its CEO is Evert B. Schimmelpennink.

For a complete fundamental analysis of Pfenex Inc., check out Equities.com’s Stock Valuation Analysis report for PFNX.

Pfenex Inc. is also a component of the Russell 2000. The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It’s maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell’s indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It’s a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

Share:
Scroll Up
error: Content is protected !!